About Excelsior Sciences
Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Round
Global Headquarters
New York, United States
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
excelsiorsci.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@foley_mfoley
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $95,000,000 · Round
fundraisingfox.com
- Capital Raise
Raised $70,000,000 · Series-A
Backed by Deerfield
Investors & Backers
Deerfield
Lead
Cornucopian Capital
Eli Lilly
Empire State Development
Illinois Ventures
Khosla Ventures
Massachusetts Institute of Technology (MIT)
Sofinnova Partners
Funding History
Round equity
· Dec 3, 2025
$95,000,000 fundraisingfox.com
Series-A equity
· Dec 3, 2025
Round backers: Deerfield
$70,000,000 fundraisingfox.com
Founders & Leadership
Bartosz Grzybowski
Founder
Work email & phone locked
Unlock →
Brian Goldman
Vice President AI And Data Sciences
Work email & phone locked
Unlock →
Jana Jensen
Founder
Work email & phone locked
Unlock →
Marc Feiglin
CTO & Head Corporate Development
Work email & phone locked
Unlock →
Martin Burke
Founder
Work email & phone locked
Unlock →
Michael Foley
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026